Document:

EXHIBIT A

THE  SECURITIES  REPRESENTED  HEREBY  MAY NOT BE  TRANSFERRED  UNLESS  (I)  SUCH
SECURITIES HAVE BEEN REGISTERED FOR SALE PURSUANT TO THE SECURITIES ACT OF 1933,
AS AMENDED,  (II) SUCH SECURITIES MAY BE SOLD PURSUANT TO RULE 144(K),  OR (III)
THE COMPANY HAS  RECEIVED AN OPINION OF COUNSEL  REASONABLY  SATISFACTORY  TO IT
THAT  SUCH  TRANSFER  MAY  LAWFULLY  BE  MADE  WITHOUT  REGISTRATION  UNDER  THE
SECURITIES ACT OF 1933 OR QUALIFICATION UNDER APPLICABLE STATE SECURITIES LAWS.

THIS WARRANT SHALL BE VOID AFTER 5:00 P.M. EASTERN STANDARD TIME ON __________,
2011 (the "EXPIRATION DATE").

                          SCIENCE DYNAMICS CORPORATION

                    WARRANT TO PURCHASE __________ SHARES OF
                     COMMON STOCK, PAR VALUE $.01 PER SHARE

         For   VALUE   RECEIVED,   _____________________________________________
("WARRANTHOLDER"),  is entitled to purchase,  subject to the  provisions of this
Warrant,  from  Science  Dynamics  Corporation,   a  Delaware  corporation  (the
"COMPANY"),  at any time not later than 5:00 P.M., Eastern Standard Time, on the
Expiration  Date (as defined  above),  at an  exercise  price per share equal to
Twelve Cents  ($0.12)  (the  exercise  price in effect  being herein  called the
"WARRANT PRICE"), ________________________________ (__________) shares ("WARRANT
SHARES")  of the  Company's  common  stock,  par value  $.01 per share  ("COMMON
STOCK").  The number of Warrant Shares purchasable upon exercise of this Warrant
and the  Warrant  Price  shall be  subject  to  adjustment  from time to time as
described herein.

         Section 1.  Registration.  The  Company  shall  maintain  books for the
transfer  and  registration  of the Warrant.  Upon the initial  issuance of this
Warrant,  the Company  shall issue and  register  the Warrant in the name of the
Warrantholder.

         Section  2.  Transfers.   As  provided  herein,  this  Warrant  may  be
transferred only pursuant to a registration statement filed under the Securities
Act of 1933,  as amended  (the  "SECURITIES  ACT"),  or an  exemption  from such
registration.  Subject to such  restrictions,  the Company  shall  transfer this
Warrant  from time to time upon the books to be  maintained  by the  Company for
that  purpose,   upon  surrender  thereof  for  transfer  properly  endorsed  or
accompanied by appropriate instructions for transfer and such other documents as
may be  reasonably  required  by the  Company,  including,  if  required  by the
Company,  an opinion of its counsel to the effect  that such  transfer is exempt
from the registration requirements of the Securities Act, to establish that such
transfer is being made in accordance  with the terms  hereof,  and a new Warrant
shall be issued to the transferee and the surrendered  Warrant shall be canceled
by the Company.

<PAGE>

         Section 3. Exercise of Warrant.  Subject to the provisions  hereof, the
Warrantholder may exercise this Warrant in whole or in part at any time prior to
its expiration upon surrender of the Warrant, together with delivery of the duly
executed  Warrant  exercise  form attached  hereto as Appendix A (the  "EXERCISE
AGREEMENT") and payment by cash, certified check or wire transfer of immediately
available  funds for the  aggregate  Warrant  Price for that  number of  Warrant
Shares then being purchased,  to the Company during normal business hours on any
business day at the Company's  principal executive offices (or such other office
or agency of the Company as it may  designate  by notice to the  Warrantholder).
The  Warrant  Shares  so  purchased   shall  be  deemed  to  be  issued  to  the
Warrantholder  or the  Warrantholder's  designee,  as the  record  owner of such
shares, as of the close of business on the date on which this Warrant shall have
been surrendered (or evidence of loss, theft or destruction thereof and security
or indemnity  satisfactory  to the  Company),  the Warrant Price shall have been
paid  and  the  completed   Exercise   Agreement   shall  have  been  delivered.
Certificates  for the Warrant  Shares so purchased,  representing  the aggregate
number of shares specified in the Exercise Agreement,  shall be delivered to the
Warrantholder  within a reasonable  time, not exceeding three (3) business days,
after this Warrant shall have been so exercised.  The  certificates so delivered
shall be in such  denominations  as may be  requested by the  Warrantholder  and
shall be registered in the name of the Warrantholder or such other name as shall
be designated by the  Warrantholder.  If this Warrant shall have been  exercised
only in part, then,  unless this Warrant has expired,  the Company shall, at its
expense,  at  the  time  of  delivery  of  such  certificates,  deliver  to  the
Warrantholder  a new Warrant  representing  the number of shares with respect to
which this Warrant shall not then have been exercised. As used herein, "BUSINESS
DAY" means a day,  other than a Saturday  or Sunday,  on which banks in New York
City are open for the general  transaction  of business.  Each  exercise  hereof
shall   constitute   the   re-affirmation   by  the   Warrantholder   that   the
representations  and  warranties  contained  in Article  II of the  Subscription
Agreement (the  "SUBSCRIPTION  AGREEMENT")  dated  __________,  2006 between the
Company and the Subscriber thereto are true and correct in all material respects
with respect to the Warrantholder as of the time of such exercise.

         Section  4.  Compliance  with the  Securities  Act of 1933.  Except  as
provided  in the  Subscription  Agreement,  the Company may cause the legend set
forth on the  first  page of this  Warrant  to be set forth on each  Warrant  or
similar legend on any security issued or issuable upon exercise of this Warrant,
unless  counsel for the Company is of the opinion as to any such  security  that
such legend is unnecessary.

         Section 5. Payment of Taxes. The Company will pay any documentary stamp
taxes  attributable to the initial  issuance of Warrant Shares issuable upon the
exercise  of the  Warrant;  provided,  however,  that the  Company  shall not be
required to pay any tax or taxes which may be payable in respect of any transfer
involved in the issuance or delivery of any certificates for Warrant Shares in a
name other than that of the  Warrantholder  in respect of which such  shares are
issued,  and in such case, the Company shall not be required to issue or deliver
any  certificate  for Warrant Shares or any Warrant until the person  requesting
the same has paid to the  Company the amount of such tax or has  established  to
the  Company's  reasonable  satisfaction  that  such  tax  has  been  paid.  The
Warrantholder shall be responsible for income taxes due under federal,  state or
other law, if any such tax is due.

                                      -2-
<PAGE>

         Section 6. Mutilated or Missing Warrants. In case this Warrant shall be
mutilated,  lost, stolen, or destroyed,  the Company shall issue in exchange and
substitution of and upon  cancellation of the mutilated  Warrant,  or in lieu of
and  substitution  for the Warrant lost,  stolen or destroyed,  a new Warrant of
like tenor and for the  purchase  of a like number of Warrant  Shares,  but only
upon receipt of evidence  reasonably  satisfactory  to the Company of such loss,
theft or  destruction  of the  Warrant,  and with  respect to a lost,  stolen or
destroyed  Warrant,  reasonable  indemnity  or bond  with  respect  thereto,  if
requested by the Company.

         Section 7. Reservation of Common Stock.  The Company hereby  represents
and  warrants  that  there  have been  reserved,  and the  Company  shall at all
applicable  times keep reserved until issued (if necessary) as  contemplated  by
this  Section 7, out of the  authorized  and  unissued  shares of Common  Stock,
sufficient  shares  to  provide  for the  exercise  of the  rights  of  purchase
represented  by this Warrant.  The Company agrees that all Warrant Shares issued
upon due  exercise  of the  Warrant  shall  be, at the time of  delivery  of the
certificates  for such Warrant Shares,  duly authorized,  validly issued,  fully
paid and non-assessable shares of Common Stock of the Company.

         Section 8. Adjustments.  Subject and pursuant to the provisions of this
Section 8, unless waived in a particular case by the Warrantholder,  the Warrant
Price and number of Warrant  Shares  subject to this Warrant shall be subject to
adjustment from time to time as set forth hereinafter.

                  (a) If the  Company  shall,  at any time or from  time to time
while this Warrant is outstanding,  pay a dividend or make a distribution on its
Common Stock in shares of Common  Stock,  subdivide  its  outstanding  shares of
Common Stock into a greater number of shares or combine its  outstanding  shares
of Common Stock into a smaller number of shares or issue by  reclassification of
its  outstanding  shares  of  Common  Stock  any  shares  of its  capital  stock
(including  any such  reclassification  in connection  with a  consolidation  or
merger in which the Company is the continuing  corporation),  then the number of
Warrant Shares purchasable upon exercise of the Warrant and the Warrant Price in
effect  immediately  prior to the date  upon  which  such  change  shall  become
effective, shall be adjusted by the Company so that the Warrantholder thereafter
exercising  the  Warrant  shall be  entitled  to receive the number of shares of
Common Stock or other capital stock which the Warrantholder  would have received
if the Warrant had been exercised  immediately  prior to such event upon payment
of a Warrant  Price that has been  adjusted to reflect a fair  allocation of the
economics of such event to the  Warrantholder.  Such  adjustments  shall be made
successively whenever any event listed above shall occur.

                  (b) If any  capital  reorganization,  reclassification  of the
capital  stock of the  Company,  consolidation  or  merger of the  Company  with
another corporation in which the Company is not the survivor,  or sale, transfer
or other  disposition  of all or  substantially  all of the Company's  assets to
another   corporation   shall  be  effected,   then,  as  a  condition  of  such
reorganization, reclassification, consolidation, merger, sale, transfer or other
disposition,   lawful  and  adequate   provision  shall  be  made  whereby  each
Warrantholder  shall  thereafter have the right to purchase and receive upon the
basis and upon the  terms and  conditions  herein  specified  and in lieu of the
Warrant Shares  immediately  theretofore  issuable upon exercise of the Warrant,
such  shares of stock,  securities  or assets  as would  have been  issuable  or
payable with  respect to or in exchange for a number of Warrant  Shares equal to
the number of Warrant Shares immediately  theretofore  issuable upon exercise of
the Warrant, had such reorganization,  reclassification,  consolidation, merger,
sale,  transfer  or other  disposition  not  taken  place,  and in any such case
appropriate  provision shall be made with respect to the rights and interests of
each  Warrantholder to the end that the provisions  hereof  (including,  without
limitation,  provision for adjustment of the Warrant Price) shall  thereafter be
applicable, as nearly equivalent as may be practicable in relation to any shares
of stock,  securities or assets thereafter deliverable upon the exercise hereof.
The Company shall not effect any such consolidation,  merger,  sale, transfer or
other  disposition  unless  prior to or  simultaneously  with  the  consummation
thereof the successor  corporation  (if other than the Company)  resulting  from
such  consolidation  or  merger,  or the  corporation  purchasing  or  otherwise
acquiring  such assets or other  appropriate  corporation or entity shall assume
the  obligation  to deliver  to the  Warrantholder,  at the last  address of the
Warrantholder  appearing  on the  books of the  Company,  such  shares of stock,
securities  or assets  as, in  accordance  with the  foregoing  provisions,  the
Warrantholder may be entitled to purchase,  and the other obligations under this
Warrant.  The  provisions  of  this  paragraph  (b)  shall  similarly  apply  to
successive reorganizations,  reclassifications,  consolidations, mergers, sales,
transfers or other dispositions.

                                      -3-
<PAGE>

                  (c) In case  the  Company  shall  fix a  payment  date for the
making of a  distribution  to all holders of Common  Stock  (including  any such
distribution  made in  connection  with a  consolidation  or merger in which the
Company is the continuing  corporation)  of evidences of  indebtedness or assets
(other than cash  dividends or cash  distributions  payable out of  consolidated
earnings or earned surplus or dividends or distributions  referred to in Section
8(a)),  or  subscription  rights or warrants,  the Warrant Price to be in effect
after such payment date shall be determined by multiplying  the Warrant Price in
effect  immediately  prior to such payment date by a fraction,  the numerator of
which shall be the total number of shares of Common Stock outstanding multiplied
by the Market  Price (as defined  below) per share of Common  Stock  immediately
prior to such payment  date,  less the fair market value (as  determined  by the
Company's  Board of  Directors  in good  faith) of said assets or  evidences  of
indebtedness so distributed, or of such subscription rights or warrants, and the
denominator  of which  shall be the total  number  of  shares  of  Common  Stock
outstanding   multiplied  by  such  Market  Price  per  share  of  Common  Stock
immediately  prior to such payment date.  "MARKET PRICE" as of a particular date
(the "VALUATION DATE") shall mean the following: (a) if the Common Stock is then
listed on a national  stock  exchange,  the  closing  sale price of one share of
Common  Stock on such  exchange on the last  trading day prior to the  Valuation
Date;  (b) if the Common Stock is then quoted on The Nasdaq Stock  Market,  Inc.
("NASDAQ"),  the National  Association of Securities Dealers,  Inc. OTC Bulletin
Board (the  "BULLETIN  BOARD") or such  similar  exchange  or  association,  the
closing sale price of one share of Common Stock on Nasdaq, the Bulletin Board or
such  other  exchange  or  association  on the  last  trading  day  prior to the
Valuation  Date or, if no such closing sale price is  available,  the average of
the high bid and the low asked  price  quoted  thereon on the last  trading  day
prior to the Valuation  Date; or (c) if the Common Stock is not then listed on a
national  stock  exchange or quoted on Nasdaq,  the Bulletin Board or such other
exchange or  association,  the fair market value of one share of Common Stock as
of the  Valuation  Date,  shall be  determined  in good  faith  by the  Board of
Directors of the Company and the Warrantholder.  If the Common Stock is not then
listed on a  national  securities  exchange,  the  Bulletin  Board or such other
exchange or  association,  the Board of Directors of the Company  shall  respond
promptly,  in writing,  to an inquiry by the Warrantholder prior to the exercise
hereunder as to the fair market  value of a share of Common Stock as  determined
by the  Board of  Directors  of the  Company.  In the  event  that the  Board of
Directors of the Company and the Warrantholder are unable to agree upon the fair
market value in respect of subpart (c) hereof, the Company and the Warrantholder
shall  jointly  select an appraiser,  who is  experienced  in such matters.  The
decision of such appraiser shall be final and  conclusive,  and the cost of such
appraiser  shall be borne  equally by the  Company and the  Warrantholder.  Such
adjustment shall be made successively whenever such a payment date is fixed.

                                      -4-
<PAGE>

                  (d) An adjustment to the Warrant Price shall become  effective
immediately  after the payment date in the case of each dividend or distribution
and  immediately  after the effective date of each other event which requires an
adjustment.

                  (e) In the  event  that,  as a result  of an  adjustment  made
pursuant to this Section 8, the  Warrantholder  shall become entitled to receive
any shares of capital  stock of the Company  other than shares of Common  Stock,
the number of such other  shares so  receivable  upon  exercise of this  Warrant
shall be subject  thereafter to adjustment  from time to time in a manner and on
terms as nearly  equivalent as practicable to the provisions with respect to the
Warrant Shares contained in this Warrant.

         Section 9.  Fractional  Interest.  The Company shall not be required to
issue  fractions  of Warrant  Shares upon the exercise of this  Warrant.  If any
fractional  share of Common Stock would,  except for the provisions of the first
sentence of this Section 9, be deliverable upon such exercise,  the Company,  in
lieu  of  delivering  such  fractional  share,   shall  pay  to  the  exercising
Warrantholder  an amount in cash  equal to the Market  Price of such  fractional
share of Common Stock on the date of exercise.

         Section 10.  Benefits.  Nothing in this  Warrant  shall be construed to
give  any  person,   firm  or  corporation  (other  than  the  Company  and  the
Warrantholder)  any legal or equitable  right,  remedy or claim, it being agreed
that this Warrant shall be for the sole and exclusive benefit of the Company and
the Warrantholder.

         Section 11. Notices to  Warrantholder.  Upon the happening of any event
requiring an adjustment of the Warrant  Price,  the Company shall  promptly give
written  notice  thereof to the  Warrantholder  at the address  appearing in the
records of the  Company,  stating the  adjusted  Warrant  Price and the adjusted
number of  Warrant  Shares  resulting  from  such  event  and  setting  forth in
reasonable  detail  the  method of  calculation  and the facts  upon  which such
calculation is based.  Failure to give such notice to the  Warrantholder  or any
defect  therein  shall not  affect  the  legality  or  validity  of the  subject
adjustment.

         Section 12. Notices.  Unless otherwise provided, any notice required or
permitted  under  this  Warrant  shall be given in  writing  and shall be deemed
effectively  given as hereinafter  described (a) if given by personal  delivery,
then such notice shall be deemed given upon such delivery, (b) if given by telex
or  facsimile,   then  such  notice  shall  be  deemed  given  upon  receipt  of
confirmation  of complete  transmittal,  (c) if given by mail,  then such notice
shall be deemed  given  upon the  earlier of (i)  receipt of such  notice by the
recipient or (ii) three days after such notice is deposited in first class mail,
postage prepaid, and (d) if given by an internationally recognized overnight air
courier,  then such notice shall be deemed given one business day after delivery
to  such  carrier.  All  notices  shall  be  addressed  as  follows:  if to  the
Warrantholder,  at its address as set forth in the  Company's  books and records
and, if to the Company,  at the address as follows,  or at such other address as
the  Warrantholder  or the Company may  designate by ten days'  advance  written
notice to the other:

                                      -5-
<PAGE>

                  If to the Company:

                  Science Dynamics Corporation
                  7150 N. Park Drive, Suite 500
                  Pennsauken, New Jersey 08109
                  Attn: Chief Executive Officer
                  Facsimile: (___) ___-____

                  With a copy to (which shall not constitute notice):

                  Sichenzia Ross Friedman Ference LLP
                  1065 Avenue of the Americas
                  New York, New York 10018
                  Attn:  Gregory Sichenzia, Esq.
                  Facsimile: (212) 930-9725

         Section 13. Registration Rights. The initial  Warrantholder is entitled
to the  benefit of certain  registration  rights  with  respect to the shares of
Common Stock  issuable  upon the exercise of this Warrant as provided in Article
IV of the Subscription Agreement.

         Section 14.  Successors.  All the covenants and provisions hereof by or
for the benefit of the Warrantholder  shall bind and inure to the benefit of its
respective successors and assigns hereunder.

         Section 15.  Governing  Law;  Consent to  Jurisdiction;  Waiver of Jury
Trial.  This Warrant shall be governed by, and construed in accordance with, the
internal laws of the State of New York,  without  reference to the choice of law
provisions   thereof.   The  Company  and,  by  accepting   this  Warrant,   the
Warrantholder,  each  irrevocably  submits to the exclusive  jurisdiction of the
courts of the State of New York  located in New York County and  federal  courts
located  in New York  County,  New York for the  purpose  of any  suit,  action,
proceeding  or  judgment  relating  to or arising  out of this  Warrant  and the
transactions contemplated hereby. Service of process in connection with any such
suit,  action or proceeding  may be served on each party hereto  anywhere in the
world by the same methods as are  specified for the giving of notices under this
Warrant.  The Company and, by accepting this Warrant,  the  Warrantholder,  each
irrevocably  consents  to the  jurisdiction  of any such court in any such suit,
action or proceeding and to the laying of venue in such court.  The Company and,
by accepting  this  Warrant,  the  Warrantholder,  each  irrevocably  waives any
objection to the laying of venue of any such suit, action or proceeding  brought
in such courts and  irrevocably  waives any claim that any such suit,  action or
proceeding brought in any such court has been brought in an inconvenient  forum.
EACH OF THE COMPANY AND, BY ITS  ACCEPTANCE  HEREOF,  THE  WARRANTHOLDER  HEREBY
WAIVES ANY RIGHT TO REQUEST A TRIAL BY JURY IN ANY  LITIGATION  WITH  RESPECT TO
THIS WARRANT AND REPRESENTS  THAT COUNSEL HAS BEEN CONSULTED  SPECIFICALLY AS TO
THIS WAIVER.

                                      -6-
<PAGE>

         Section  16. No Rights as  Stockholder.  Prior to the  exercise of this
Warrant,  the  Warrantholder  shall  not  have  or  exercise  any  rights  as  a
stockholder of the Company by virtue of its ownership of this Warrant.

         Section 17. Amendment;  Waiver. Any term of this Warrant may be amended
or  waived  upon the  written  consent  of the  Company  and the  holder of this
Warrant.

         Section 18. Section Headings.  The section headings in this Warrant are
for the  convenience of the Company and the  Warrantholder  and in no way alter,
modify, amend, limit or restrict the provisions hereof.

         IN WITNESS  WHEREOF,  the Company  has caused  this  Warrant to be duly
executed, as of the ____ day of __________ 2006.

                                   SCIENCE DYNAMICS CORPORATION

                                   By:
                                       ----------------------------------------
                                   Name: Paul Burgess
                                   Title: Chief Executive Officer

                                      -7-
<PAGE>

                                   APPENDIX A
                          SCIENCE DYNAMICS CORPORATION
                              WARRANT EXERCISE FORM

To Science Dynamics Corporation:

         The  undersigned  hereby  irrevocably  elects to exercise  the right of
purchase  represented  by the within  Warrant  ("WARRANT")  for, and to purchase
thereunder  by the payment of the Warrant  Price and  surrender  of the Warrant,
_______________  shares of Common Stock ("WARRANT SHARES") provided for therein,
and requests that certificates for the Warrant Shares be issued as follows:

                           -------------------------------------
                           Name

                           -------------------------------------
                           -------------------------------------
                           Address

                           -------------------------------------
                           Federal Tax ID or Social Security No.

         and   delivered  by   (certified   mail  to  the  above   address,   or
(electronically  (provide  DWAC  Instructions:  ___________________),  or (other
(specify):                                                ______________________
_______________________________________________________________________),   and,
if the number of Warrant Shares shall not be all the Warrant Shares  purchasable
upon exercise of the Warrant,  that a new Warrant for the balance of the Warrant
Shares  purchasable  upon  exercise of this Warrant be registered in the name of
the undersigned  Warrantholder or the undersigned's  Assignee as below indicated
and delivered to the address stated below.

         By signing below, the undersigned  hereby  represents that he or she is
an  "ACCREDITED  INVESTOR"  as such term is defined in Rule 501 of  Regulation D
promulgated under the Securities Act and the undersigned further re-affirms that
the representations  and warranties  contained in Article II of the Subscription
Agreement (the  "SUBSCRIPTION  AGREEMENT")  dated  __________,  2006 between the
Company and the Subscriber thereto are true and correct in all material respects
with respect to the Warrantholder as of the time this exercise.

Dated: ___________________, _____

Note:  The  signature  must  correspond  with the name of the  Warrantholder  as
written on the first page of the Warrant in every particular, without alteration
or enlargement or any change whatever, unless the Warrant has been assigned.

                       Warrant Signature:
                                            ------------------------------------

                       Name (please print):
                                            ------------------------------------

                                            ------------------------------------
                                            ------------------------------------
                                            Address

                                            ------------------------------------
                                            Federal Identification or
                                            Social Security No.SCIENCE DYNAMICS CORPORATION
                             SUBSCRIPTION AGREEMENT

         SUBSCRIPTION  AGREEMENT (this "AGREEMENT") made as of the last date set
forth on the signature  page hereof  between  Science  Dynamics  Corporation,  a
Delaware  corporation  with  offices  located at 7150 N. Park Drive,  Suite 500,
Pennsauken,   New  Jersey  08109  (the  "COMPANY"),  and  the  undersigned  (the
"SUBSCRIBER").

         WHEREAS,  pursuant to Section 4(2) of the  Securities  Act of 1933,  as
amended (the "SECURITIES ACT"), and Rule 506 promulgated thereunder, the Company
desires to sell up to  $2,000,000  of units (the  "UNITS") of the Company,  in a
private  placement  (the "PRIVATE  PLACEMENT")  on the terms and  conditions set
forth herein;

         WHEREAS,  each Unit  shall  have a  subscription  price of $6.00 and is
comprised  of: (i) one hundred  shares of the Company's  common stock,  $.01 par
value per share ("COMMON STOCK"), and (ii) a warrant to purchase fifty shares of
Common Stock with an exercise price of $0.12 per share, exercisable for a period
of five years,  in the form  attached  hereto as Exhibit A (each a "WARRANT" and
collectively,  the  "WARRANTS")  (the Common Stock,  the Warrants and the Common
Stock issuable upon exercise of the Warrants are sometimes collectively referred
to herein as the "SECURITIES"; and

         WHEREAS,  the  Subscriber  desires to purchase that number of Units set
forth on the signature page hereof on the terms and conditions  hereinafter  set
forth.

         NOW, THEREFORE, for and in consideration of the premises and the mutual
covenants hereinafter set forth, the parties hereto do hereby agree as follows:

         I.       SUBSCRIPTION FOR SECURITIES; PURCHASE PRICE AND CLOSING

                  In   consideration   of  and  in  express  reliance  upon  the
representations,  warranties, covenants, terms and conditions of this Agreement,
the Subscriber hereby irrevocably subscribes for and agrees to purchase from the
Company such number of Units,  and the Company  agrees to sell to the Subscriber
such number of Units, as is set forth on the signature page hereof.  The closing
of the purchase and sale of the Units under this  Agreement  shall take place at
the offices of the Company (the "CLOSING") at 10:00 a.m. on April 28, 2006 or at
such time and on such date as the  Subscriber and the Company may agree upon. At
the  Closing,  the  Company  shall  deliver  or  cause to be  delivered  to each
Subscriber:  (a)  a  certificate  registered  in  the  name  of  the  Subscriber
representing  the number of shares of Common Stock as is set forth  opposite the
name of such Subscriber on the signature page hereof;  (b) a Warrant  registered
in the name of the  Subscriber to purchase such number of shares of Common Stock
as is set forth  opposite  the name of such  Subscriber  on the  signature  page
hereof;  and (c) a copy of this  Agreement  countersigned  by the  Company.  The
Closing is expressly  conditioned upon the Company signing and delivering a copy
of this Agreement to the Subscriber.

         II.      REPRESENTATIONS BY AND COVENANTS OF SUBSCRIBER

                  The Subscriber represents, warrants and agrees as follows:

                                       1
<PAGE>

                  2.1 RELIANCE ON EXEMPTIONS.  The Subscriber  acknowledges that
the Private  Placement has not been reviewed by the United States Securities and
Exchange  Commission  (the  "COMMISSION")  or any  state  agency  because  it is
intended to be a nonpublic transaction exempt from the registration requirements
of the Securities Act and state securities laws. The Subscriber understands that
the  Company is relying  upon the truth and  accuracy  of, and the  Subscriber's
compliance with, the representations,  warranties,  agreements,  acknowledgments
and  understandings of the Subscriber set forth herein in order to determine the
availability of such exemption and the eligibility of the Subscriber to purchase
the Securities.

                  2.2 INVESTMENT  PURPOSE.  The Subscriber  represents  that the
Securities are being purchased for its own account, for investment purposes only
and  not  for   distribution  or  resale  to  others  in  contravention  of  the
registration  requirements of the Securities Act. The Subscriber  agrees that it
will not sell or otherwise  transfer the  Securities  unless they are registered
under the  Securities  Act or  unless an  exemption  from such  registration  is
available.

                  2.3  ACCREDITED  INVESTOR.   The  Subscriber   represents  and
warrants that it is an "accredited investor" as such term is defined in Rule 501
of Regulation D  promulgated  under the  Securities  Act, and that it is able to
bear the economic  risk of any  investment  in the  Securities.  The  Subscriber
represents that if an individual,  he has adequate means of providing for his or
her current  needs and  personal  and family  contingencies  and has no need for
liquidity in this investment in the Securities.  The Subscriber has no reason to
anticipate any material  change in his or her personal  financial  condition for
the foreseeable  future. The Subscriber further represents and warrants that the
information  furnished in the accompanying  accredited  investor  questionnaire,
which is attached  hereto as Exhibit B, is accurate and complete in all material
respects.

                  2.4  INTEREST IN UNITS.  The  Subscriber  represents  that the
funds provided for this investment in the Units are either separate  property of
the  Subscriber,  community  property over which the Subscriber has the right of
control, or are otherwise funds as to which the Subscriber has the sole right of
management.  The  Subscriber  is  purchasing  the  Units  with the  funds of the
Subscriber  and not with the funds of any other  person,  firm, or entity and is
acquiring  the Units for the  Subscriber's  account.  No person  other  than the
Subscriber has any beneficial interest in the Units being purchased hereunder.

                  2.5  RISK  OF  INVESTMENT.   The  Subscriber  understands  and
acknowledges that the purchase of the Securities  involves a high degree of risk
in that:  (a) an  investment  in the  Company  is  highly  speculative  and only
investors  who can afford the loss of their entire  investment  should  consider
investing  in the  Company  and  the  Securities;  (b)  the  Securities  will be
"restricted  securities"  (as defined in Securities Act Rule  144(a)(3)) and may
not be  resold  unless  they  are  registered  under  the  Securities  Act or an
exemption from  registration is available;  (c) the Subscriber does not have the
protection  of Section 11 of the  Securities  Act;  (d) the Company has recently
abandoned  a public  offering  by filing a  request  to  withdraw  its Form SB-2
registration statement (SEC File No. 333-128142), which withdrawal was effective
upon filing on March 27,  2006;  and (e) the  Company  may  require  substantial
additional funds to operate its business and subsequent  equity  financings will
dilute the ownership and voting interests of the Subscriber.

                                       2
<PAGE>

                  2.6 PRIOR INVESTMENT EXPERIENCE.  The Subscriber  acknowledges
that it has  prior  investment  experience  and that it  recognizes  the  highly
speculative nature of this investment.

                  2.7 INFORMATION. The Subscriber acknowledges careful review of
this Agreement as well as the Company's filings with the Commission, as required
pursuant to the  Securities  and Exchange Act of 1934, as amended (the "EXCHANGE
ACT"),  which are available on the Internet at  www.sec.gov  (collectively,  the
"DISCLOSURE MATERIALS"), all of which the Subscriber acknowledges have been made
available to him. The Subscriber has been given the opportunity to ask questions
of, and receive answers from, the Company concerning the terms and conditions of
this  Private  Placement  and  the  Disclosure  Materials  and  to  obtain  such
additional information,  to the extent the Company possesses such information or
can acquire it without  unreasonable effort or expense,  necessary to verify the
accuracy of same as the Subscriber  reasonably  desires in order to evaluate the
investment.  The  Subscriber  understands  the  Disclosure  Materials,  and  the
Subscriber has had the opportunity to discuss any questions regarding any of the
Disclosure  Materials with his counsel or other  advisors.  Notwithstanding  the
foregoing, the only information upon which the Subscriber has relied is that set
forth  in  the   Disclosure   Materials.   The   Subscriber   has   received  no
representations  or  warranties  from the  Company,  its  employees,  agents  or
attorneys  in making  this  investment  decision  other than as set forth in the
Disclosure  Materials.  The  Subscriber  does not desire to receive  any further
information.

                  2.8 NO REPRESENTATIONS. The Subscriber hereby represents that,
except  as  expressly  set  forth  in  this  Agreement,  no  representations  or
warranties  have  been  made to the  Subscriber  by the  Company  or any  agent,
employee or affiliate of the Company,  and in entering into this transaction the
Subscriber is not relying on any  information  other than that  contained in the
Disclosure  Materials  and  the  results  of  independent  investigation  by the
Subscriber.

                  2.9 TAX  CONSEQUENCES.  The Subscriber  acknowledges  that the
Private  Placement  may involve tax  consequences  and that the  contents of the
Disclosure  Materials do not contain tax advice or  information.  The Subscriber
acknowledges  that it must retain its own professional  advisors to evaluate the
tax and other consequences of an investment in the Units.

                  2.10 TRANSFER OR RESALE. The Subscriber understands and hereby
acknowledges  that the Company is under no obligation to register the Securities
under the Securities  Act except as contained  herein.  The Subscriber  consents
that the Company may, if it desires, permit the transfer of the Units out of the
Subscriber's name only when the Subscriber's request for transfer is accompanied
by an opinion of counsel reasonably satisfactory to the Company that neither the
sale nor the proposed  transfer  results in a violation of the Securities Act or
any applicable state "blue sky" laws.

                  2.11 LEGENDS. The Subscriber understands that the certificates
representing the Securities, until such time as their resale has been registered
under the Securities Act, shall bear a restrictive  legend in substantially  the
following form (and a stop-transfer order may be placed against transfer of such
certificates or other instruments):

                                       3
<PAGE>

                  THE SECURITIES  REPRESENTED BY THIS  CERTIFICATE HAVE NOT BEEN
                  REGISTERED  UNDER THE SECURITIES  ACT OF 1933, AS AMENDED,  OR
                  APPLICABLE  STATE  SECURITIES  LAWS. THE SECURITIES MAY NOT BE
                  OFFERED FOR SALE,  SOLD,  TRANSFERRED  OR ASSIGNED  (I) IN THE
                  ABSENCE OF (A) AN  EFFECTIVE  REGISTRATION  STATEMENT  FOR THE
                  SECURITIES  UNDER THE SECURITIES  ACT OF 1933, AS AMENDED,  OR
                  APPLICABLE  STATE  SECURITIES  LAWS,  OR  (B)  AN  OPINION  OF
                  COUNSEL, IN A REASONABLY ACCEPTABLE FORM, THAT REGISTRATION IS
                  NOT REQUIRED  UNDER SAID ACT OR  APPLICABLE  STATE  SECURITIES
                  LAWS, OR (II) UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT.

                  The legend set forth  above  shall be removed  and the Company
shall issue a  certificate  without such legend to the holder of the  Securities
upon which it is stamped,  if (a) such  Securities  are being sold pursuant to a
registration statement under the Securities Act, (b) such holder delivers to the
Company an opinion of counsel,  in a reasonably  acceptable form, to the Company
that a disposition of the Securities is being made pursuant to an exemption from
such  registration,  or (c) such holder  provides  the Company  with  reasonable
assurance  that a disposition of the Securities may be made pursuant to the Rule
144(k)  under the  Securities  Act without any  restriction  as to the number of
Securities acquired as of a particular date that can then be immediately sold.

                  2.12 NO GENERAL  SOLICITATION.  The Subscriber represents that
it was not  induced  to invest by any form of  general  solicitation  or general
advertising including, but not limited to, the following: (a) any advertisement,
article, notice or other communication  published in any newspaper,  magazine or
similar  media or  broadcast  over the news or  radio;  and (b) any  seminar  or
meeting whose attendees were invited by any general solicitation or advertising.

                  2.13   VALIDITY;   ENFORCEMENT.   If  the   Subscriber   is  a
corporation,  partnership,  trust or other entity, the Subscriber represents and
warrants that: (a) it is authorized and otherwise duly qualified to purchase and
hold  the  Units;  and (b)  that  this  Agreement  has  been  duly  and  validly
authorized,  executed  and  delivered  and  constitutes  the legal,  binding and
enforceable  obligation of the  Subscriber.  If the Subscriber is an individual,
the  Subscriber  represents  and warrants that this  Agreement has been duly and
validly   executed  and  delivered  and  constitutes  the  legal,   binding  and
enforceable obligation of the Subscriber.

                  2.14  ADDRESS.  The  Subscriber  hereby  represents  that  the
address  of the  Subscriber  furnished  by the  Subscriber  at the  end of  this
Agreement  is the  Subscriber's  principal  residence  if the  Subscriber  is an
individual or its  principal  business  address if it is a corporation  or other
entity.

                                       4
<PAGE>

         III.     REPRESENTATIONS BY AND COVENANTS OF THE COMPANY

                  The Company represents, warrants and agrees as follows:

                  3.1  ORGANIZATION.  The Company is duly  organized and validly
existing in good standing  under the laws of the State of Delaware.  The Company
has full power and authority to own,  operate and occupy its  properties  and to
conduct its business as presently  conducted,  and is registered or qualified to
do business and in good standing in each jurisdiction in which the nature of the
business conducted by it or the location of the properties owned or leased by it
requires such  qualification and where the failure to be so qualified would have
a material  adverse effect upon the Company's  financial  condition (a "MATERIAL
ADVERSE EFFECT"), and no proceeding has been instituted in any such jurisdiction
revoking,  limiting or curtailing,  or seeking to revoke, limit or curtail, such
power and authority or qualification.

                  3.2 DUE AUTHORIZATION AND VALID ISSUANCE.  The Company has all
requisite  power and authority to execute,  deliver and perform its  obligations
under this  Agreement,  and when  executed  and  delivered  by the Company  this
Agreement will  constitute a legal,  valid and binding  agreement of the Company
enforceable  against the Company in accordance with its terms,  except as rights
to indemnity and contribution may be limited by state or federal securities laws
or the public policy underlying such laws, and except as  enforceability  may be
limited by  applicable  bankruptcy,  insolvency,  reorganization,  moratorium or
similar laws affecting creditors' and contracting parties' rights generally, and
except  as  enforceability  may be  subject  to  general  principles  of  equity
(regardless  of whether such  enforceability  is  considered  in a proceeding in
equity or at law). The  securities  which comprise the Units to be sold pursuant
to this  Agreement  have been duly  authorized,  and when issued and paid for in
accordance  with the terms of this  Agreement  will be duly and validly  issued,
fully paid and nonassessable

                  3.3  NONCONTRAVENTION.  The  execution  and  delivery  of this
Agreement and the consummation of the transactions contemplated hereby will not:
(a) conflict  with or constitute a violation of, or default (with the passage of
time or  otherwise)  under  (i) any  material  bond,  debenture,  note or  other
evidence of indebtedness,  lease, contract, indenture,  mortgage, deed of trust,
loan  agreement,  joint  venture or other  agreement or  instrument to which the
Company is a party or by which it or any of its  properties  are bound,  or (ii)
the  charter,  bylaws or other  organizational  documents  of the Company or any
subsidiary;   or  (b)  result  in  the  creation  or  imposition  of  any  lien,
encumbrance,  claim, security interest or restriction whatsoever upon any of the
material  properties or assets of the Company or an acceleration of indebtedness
pursuant to any  obligation,  agreement or  condition  contained in any material
bond,  debenture,  note  or  any  other  evidence  of  indebtedness,  indenture,
mortgage,  deed of trust or any  other  agreement  or  instrument  to which  the
Company  is a party or by which  it is  bound  or to which  any of the  material
property or assets of the Company is subject.

                  3.4 NO VIOLATION.  The Company is not: (a) in violation of its
charter,  bylaws or other organizational  document; or (b) in default (and there
exists  no  condition  that,  with  the  passage  of  time or  otherwise,  would
constitute a default) in any material  respect in the  performance of a material
agreement or  instrument to which the Company is a party or by which the Company
is bound or by which the  properties  of the  Company  are bound,  that would be
reasonably likely to have a Material Adverse Effect. The business of the Company
is not being conducted,  and shall not be conducted so long as the investors own
any of the Units, in violation of any law, ordinance,  rule, regulation,  order,
judgment or decree of any governmental  entity,  court or arbitration  tribunal,
except for possible  violations  the sanctions for which either singly or in the
aggregate would not have a Material Adverse Effect.

                                       5
<PAGE>

                  3.5 LEGAL  PROCEEDINGS.  Except as otherwise  disclosed in the
Disclosure Materials,  there is no action, suit, proceeding, or to the knowledge
of the Company,  inquiry or investigation  before or by any court, public board,
governmental  agency  or  authority,  or  self-regulatory  organization  or body
pending or, to the knowledge of the Company, threatened against or affecting the
Company or any of its directors or officers in their capacities as such, wherein
an unfavorable decision,  ruling or finding would have a Material Adverse Effect
or would adversely  affect the Private  Placement or that would adversely affect
the validity or enforceability of, or the authority or ability of the Company to
consummate the Private Placement.

                  3.6 GOVERNMENTAL  PERMITS,  ETC. The Company has all necessary
franchises,  licenses,  certificates and other  authorizations from any foreign,
federal, state or local government or governmental agency,  department,  or body
that are currently necessary for the operation of the business of the Company as
currently  conducted,  except where the failure to currently  possess  could not
reasonably be expected to have a Material Adverse Effect.

                  3.7 INTELLECTUAL  PROPERTY.  (a) The Company owns or possesses
sufficient  rights  to use all  material  patents,  patent  rights,  trademarks,
copyrights,  licenses,  inventions,  trade  secrets,  trade  names and  know-how
(collectively, "INTELLECTUAL PROPERTY") as owned or possessed by it, or that are
necessary  for the conduct of its business as now conducted or as proposed to be
conducted, except where the failure to currently own or possess would not have a
Material Adverse Effect,  (b) the Company has not received any notice of, or has
any knowledge of, any asserted  infringement  by the Company of, any rights of a
third party with respect to any Intellectual  Property that,  individually or in
the aggregate, would have a Material Adverse Effect, and (c) the Company has not
received any notice of, or has no knowledge  of,  infringement  by a third party
with  respect  to  any  Intellectual   Property  rights  of  the  Company  that,
individually or in the aggregate, would have a Material Adverse Effect.

                  3.8  FINANCIAL  STATEMENTS.  The  financial  statements of the
Company included in the Company's filings with the Commission have been prepared
in accordance with U.S. generally accepted accounting  principles,  consistently
applied,  during the periods involved  (except as may be otherwise  indicated in
such  financial  statements  or the notes  thereto,  or in the case of unaudited
interim statements, to the extent they do not include footnotes or are condensed
or  summary  statements)  and  fairly  present  in  all  material  respects  the
consolidated financial position of the Company and its consolidated subsidiaries
as of the dates thereof and the  consolidated  results of their  operations  and
cash  flows  for the  periods  then  ended  (subject,  in the case of  unaudited
statements,  to normal,  immaterial year-end audit  adjustments).  Except as set
forth in the  financial  statements  of the Company  included  in the  Company's
filings  with the  Commission,  the Company has no  liabilities,  contingent  or
otherwise,  other than (a) liabilities  incurred  subsequent to the date of such
financial  statements in the ordinary  course of business  consistent  with past
practice and (b) obligations  under  contracts and  commitments  incurred in the
ordinary  course of business  and not  required  under U.S.  generally  accepted
accounting principles to be reflected in such financial statements, in each case
that,  individually  or in the  aggregate,  are not  material  to the  financial
condition, business, operations,  properties,  operating results or prospects of
the Company and its subsidiaries taken on a whole.

                                       6
<PAGE>

                  3.9 DISCLOSURE.  None of the representations and warranties of
the Company  appearing in this Agreement  contains,  or on any closing date will
contain,  any untrue  statement of a material  fact or omits,  or on any closing
date  will omit to state  any  material  fact  required  to be stated  herein or
therein  in  order  for the  statements  herein  or  therein,  in  light  of the
circumstances under which they were made, not to be misleading.

         IV.      REGISTRATION RIGHTS

                  The Company  agrees that if, at any time after the date hereof
the Company shall determine to file with the Commission a registration statement
(the  "REGISTRATION  STATEMENT")  relating to an offering for its own account or
the account of others under the Securities  Act of any of its equity  securities
(other than on Form S-4 or Form S-8 or their then equivalents relating to equity
securities to be issued solely in connection  with an  acquisition of any entity
or business or equity  securities  issuable in connection with employee  benefit
plans),  the Company  shall  include in such  Registration  Statement all of the
shares of Common Stock purchased hereunder and all of the shares of Common Stock
issuable upon exercise of the Warrants,  all as indicated on the signature  page
hereof (the "REGISTRABLE SECURITIES"). The Company shall use its best efforts to
cause the Registration  Statement to be declared  effective by the Commission as
promptly as possible  after the filing thereof and shall use its best efforts to
keep the Registration  Statement continuously effective under the Securities Act
until the earlier of: (a) the date when all  Registrable  Securities  covered by
such  Registration  Statement have been sold publicly;  or (b) the date when all
Registrable  Securities may be sold pursuant to Rule 144(k) under the Securities
Act.  Notwithstanding any other provision of this Article IV, the Company may at
any time, abandon or delay any Registration  Statement filed by the Company.  In
the event of such abandonment by the Company, the Company shall remain obligated
to register the resale of the Registrable Securities pursuant to this Article IV
until the earlier  of: (a) the date when all  Registrable  Securities  have been
sold by the Subscriber;  or (b) the date when all Registrable  Securities may be
sold pursuant to Rule 144(k) under the Securities Act.

         V.       MISCELLANEOUS

                  5.1  NOTICE.   Any   notices,   consents,   waivers  or  other
communications  required  or  permitted  to be  given  under  the  terms of this
Agreement must be in writing and will be deemed to have been delivered: (a) upon
receipt,  when delivered  personally,  (b) upon receipt,  when sent by facsimile
(provided   confirmation  of  transmission  is  mechanically  or  electronically
generated  and kept on file by the sending  party),  or (c) one (1) business day
after deposit with an overnight courier service, in each case properly addressed
to the party to receive the same.  The addresses and facsimile  numbers for such
communications shall be:

                                       7
<PAGE>

                  If to the Company:

                  Science Dynamics Corporation
                  7150 N. Park Drive, Suite 500
                  Pennsauken, New Jersey 08109
                  Attn: Chief Executive Officer
                  Facsimile: (856) 910-1811

                  With a copy to (which shall not constitute notice):

                  Sichenzia Ross Friedman Ference LLP
                  1065 Avenue of the Americas
                  New York, New York 10018
                  Attn:  Gregory Sichenzia, Esq.
                  Facsimile: (212) 930-9725

                  If to the Subscriber,  to its address and facsimile number set
forth at the end of this  Agreement,  or to such other address and/or  facsimile
number  and/or to the  attention  of such other  person as  specified by written
notice  given to the Company  five (5) days prior to the  effectiveness  of such
change.  Written  confirmation  of receipt  (a) given by the  recipient  of such
notice,   consent,   waiver  or  other   communication,   (b)   mechanically  or
electronically  generated by the sender's facsimile machine containing the time,
date,  recipient  facsimile  number  and an  image  of the  first  page  of such
transmission,  or  (c)  provided  by  an  overnight  courier  service  shall  be
rebuttable evidence of personal service, receipt by facsimile or receipt from an
overnight  courier  service in  accordance  with clause  (a),  (b) or (c) above,
respectively.

                  5.2 ENTIRE AGREEMENT; AMENDMENT. This Agreement supersedes all
other prior oral or written  agreements  between the  Subscriber,  the  Company,
their  affiliates and persons acting on their behalf with respect to the matters
discussed  herein,  and this  Agreement and the  instruments  referenced  herein
contain  the entire  understanding  of the parties  with  respect to the matters
covered  herein and therein  and,  except as  specifically  set forth  herein or
therein,  neither  the  Company  nor the  Subscriber  makes any  representation,
warranty,  covenant or undertaking with respect to such matters. No provision of
this  Agreement  may be amended or waived other than by an instrument in writing
signed by the Company and the Subscriber.

                  5.3 SEVERABILITY.  If any provision of this Agreement shall be
invalid   or   unenforceable   in   any   jurisdiction,   such   invalidity   or
unenforceability  shall  not  affect  the  validity  or  enforceability  of  the
remainder  of  this   Agreement  in  that   jurisdiction   or  the  validity  or
enforceability of any provision of this Agreement in any other jurisdiction.

                  5.4 GOVERNING  LAW;  JURISDICTION;  WAIVER OF JURY TRIAL.  All
questions concerning the construction,  validity, enforcement and interpretation
of this  Agreement  shall be governed by the  internal  laws of the State of New
York, without giving effect to any choice of law or conflict of law provision or
rule  (whether of the State of New York or any other  jurisdictions)  that would
cause the application of the laws of any  jurisdictions  other than the State of
New  York.  Each  party  hereby   irrevocably   submits  to  the   non-exclusive
jurisdiction  of the state and federal courts sitting in the County of New York,
State of New York for the adjudication of any dispute hereunder or in connection
herewith or with any transaction  contemplated  hereby or discussed herein,  and
hereby  irrevocably  waives,  and  agrees  not to assert in any suit,  action or
proceeding,  any claim that it is not personally  subject to the jurisdiction of
any  such  court,  that  such  suit,  action  or  proceeding  is  brought  in an
inconvenient  forum or that the  venue of such  suit,  action or  proceeding  is
improper.  Each party hereby  irrevocably waives personal service of process and
consents  to process  being  served in any such suit,  action or  proceeding  by
mailing a copy thereof to such party at the address for such notices to it under
this Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof.  Nothing contained herein shall be deemed
to limit in any way any right to serve  process in any manner  permitted by law.
Each party hereby  irrevocably  waives any right it may have,  and agrees not to
request,  a jury  trial for the  adjudication  of any  dispute  hereunder  or in
connection with or arising out of this Agreement or any transaction contemplated
hereby.

                                       8
<PAGE>

                  5.5  HEADINGS.   The  headings  of  this   Agreement  are  for
convenience   of   reference   and  shall  not  form  part  of,  or  affect  the
interpretation of, this Agreement.

                  5.6  SUCCESSORS AND ASSIGNS.  This Agreement  shall be binding
upon and inure to the benefit of the parties and their respective successors and
assigns.  The  Company  shall  not  assign  this  Agreement  or  any  rights  or
obligations  hereunder  without the prior  written  consent of the holders of at
least a majority the Units then outstanding,  except by merger or consolidation.
The Subscriber shall not assign its rights hereunder  without the consent of the
Company, which consent shall not be unreasonably withheld.

                  5.7 NO THIRD PARTY  BENEFICIARIES.  This Agreement is intended
for the benefit of the parties hereto and their respective  permitted successors
and  assigns,  and is not for the  benefit of, nor may any  provision  hereof be
enforced by, any other person.

                  5.8  SURVIVAL.  The  representations  and  warranties  of  the
Subscriber  and the Company  contained in Articles II and III and the agreements
set forth this Article V shall survive closing for a period of two years.

                  5.9 FURTHER  ASSURANCES.  Each party shall do and perform,  or
cause to be done and  performed,  all such  further  acts and things,  and shall
execute and deliver all such other  agreements,  certificates,  instruments  and
documents,  as the other party may reasonably  request in order to carry out the
intent and accomplish the purposes of this Agreement and the consummation of the
transactions contemplated hereby.

                  5.10  NO  STRICT  CONSTRUCTION.  The  language  used  in  this
Agreement  will be deemed to be the  language  chosen by the  parties to express
their mutual intent, and no rules of strict construction will be applied against
any party.

                                       9
<PAGE>

                  5.11 LEGAL REPRESENTATION.  The Subscriber  acknowledges that:
(a) it has read this Agreement and the exhibits hereto;  (b) it understands that
the Company has been represented in the preparation,  negotiation, and execution
of this  Agreement  by  Sichenzia  Ross  Friedman  Ference  LLP,  counsel to the
Company; and (c) it understands the terms and consequences of this Agreement and
is fully aware of its legal and binding effect.

                  5.12  COUNTERPARTS.  This  Agreement may be executed in two or
more identical  counterparts,  all of which shall be considered one and the same
agreement and shall become effective when  counterparts have been signed by each
party and  delivered to the other  party;  provided  that a facsimile  signature
shall be  considered  due  execution  and shall be  binding  upon the  signatory
thereto with the same force and effect as if the signature were an original, not
a facsimile signature.

                            [SIGNATURE PAGE FOLLOWS]

                                       10
<PAGE>

         IN WITNESS WHEREOF,  the parties have executed this Agreement as of the
day and year written below.

______________________________________   Purchase Price:________________________
Name of Subscriber                       Securities Purchased:
                                         # of Shares of Common Stock:___________
                                         # of Warrant Shares Purchasable:_______

--------------------------------------
Signature

--------------------------------------
Name (If Subscriber is an entity,
trust or other organization)
(Please Print)

--------------------------------------
Title (If Subscriber is an entity,
trust or other organization)
(Please Print)

--------------------------------------

--------------------------------------

--------------------------------------
Address of Subscriber

--------------------------------------
Taxpayer Identification Number
of Subscriber

                                         Subscription Accepted:

                                         This ___ day of _______________, 2006

                                         SCIENCE DYNAMICS CORPORATION

                                         By:___________________________________
                                         Name:  Paul Burgess
                                         Title:    Chief Executive Officer

                                       11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}]]